Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Metin Cetin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cell Death and Differentiation|March 2, 2023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplificationOzge Saatci, Ozge Akbulut, Metin Cetin, et al.
Cell Chemical Biology|July 23, 2024
A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancerMetin Cetin, Ozge Saatci, Abdol-Hossein Rezaeian, et al.
Stress (Amsterdam, Netherlands)|July 31, 2023
Psychological, endocrine and polygenic predictors of emotional well-being during the COVID-19 pandemic in a longitudinal birth cohortThao Nguyen, Lea Zillich, Metin Cetin, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
Cancer Research|February 6, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast CancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
Molecular Oncology|May 1, 2021
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancerRahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Targeting LINC00152 activates cAMP/Ca<sup>2+</sup>/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancerOzge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam, et al.
Cell Death & Disease|June 15, 2024
Targeting LINC00152 activates cAMP/Ca<sup>2+</sup>/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancerOzge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, et al.
Alcohol, Clinical & Experimental Research|January 26, 2024
Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorderLea Zillich, Metin Cetin, Elisabeth M Hummel, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cell Death and Differentiation|March 2, 2023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplificationOzge Saatci, Ozge Akbulut, Metin Cetin, et al.
Cell Chemical Biology|July 23, 2024
A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancerMetin Cetin, Ozge Saatci, Abdol-Hossein Rezaeian, et al.
Stress (Amsterdam, Netherlands)|July 31, 2023
Psychological, endocrine and polygenic predictors of emotional well-being during the COVID-19 pandemic in a longitudinal birth cohortThao Nguyen, Lea Zillich, Metin Cetin, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
Cancer Research|February 6, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast CancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
Molecular Oncology|May 1, 2021
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancerRahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Targeting LINC00152 activates cAMP/Ca<sup>2+</sup>/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancerOzge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam, et al.
Cell Death & Disease|June 15, 2024
Targeting LINC00152 activates cAMP/Ca<sup>2+</sup>/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancerOzge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, et al.
Alcohol, Clinical & Experimental Research|January 26, 2024
Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorderLea Zillich, Metin Cetin, Elisabeth M Hummel, et al.
Pageof 2